Global Migraine Drugs Market 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
January 11, 2023 05:28 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Botulinum Toxin Market Report 2022: Market to Reach $7.9 Billion by 2026 - Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
June 20, 2022 05:18 ET
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Botulinum Toxin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Botulinum Toxin Market...
Worldwide Migraine Drugs Industry to 2026 - Featuring Allergan, Amgen and Eisai Among Others
October 22, 2021 08:33 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Migraine Drugs Market to 2025: Growing Demand for Electrical Nerve Stimulating Devices to Treat Migraine
December 15, 2020 05:08 ET
|
Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
New Research to Confirm Why BrainHQ Exercises Work Across Diverse Populations
October 01, 2019 08:00 ET
|
Posit Science
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Posit Science, the maker of BrainHQ computerized brain exercises, has been awarded a federal grant to measure the impact of BrainHQ training on the...
Alzheimer’s-related Study: Brain Training Upregulates Acetylcholine
July 24, 2018 08:00 ET
|
Posit Science
CHICAGO, July 24, 2018 (GLOBE NEWSWIRE) -- A small study could have big implications in the battle against age-related cognitive decline and dementia, according to research announced today at the...